North America Antithrombotic Pressure Pump Market Size & Forecast:
- North America Antithrombotic Pressure Pump Market Size 2025: USD 73.8 Million
- North America Antithrombotic Pressure Pump Market Size 2033: USD 121.7 Million
- North America Antithrombotic Pressure Pump Market CAGR: 6.48%
- North America Antithrombotic Pressure Pump Market Segments: By Product Type (Intermittent Pneumatic Compression Pumps, Sequential Compression Pumps, Portable Pumps, Battery-Operated Pumps, Single-Chamber Pumps, Multi-Chamber Pumps, Smart Pumps, Others); By Application (Deep Vein Thrombosis Prevention, Post-Surgical Care, Critical Care, Orthopedic Procedures, Vascular Disorders, Trauma Care, Rehabilitation, Others); By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Rehabilitation Centers, Homecare, Long-Term Care Centers, Specialty Centers, Others); By Technology (Digital Monitoring, Wireless Connectivity, AI-Enabled Systems, Pressure Sensors, Portable Systems, Smart Monitoring, Remote Monitoring, Others); By Distribution Channel (Direct Sales, Medical Distributors, Hospital Procurement, Online Sales, Specialty Suppliers, GPOs, Dealers, Others).

North America Antithrombotic Pressure Pump Market Summary
The North America Antithrombotic Pressure Pump Market was valued at USD 73.8 Million in 2025. It is forecast to reach USD 121.7 Million by 2033. That is a CAGR of 6.48% over the period.
The North America Antithrombotic Pressure Pump Market kind of supports hospitals and surgical centers by pushing a controlled level of pressure during procedures, while also helping bring down the risk of blood clot formation that can happen with long immobility or when circulation is compromised. In real terms these systems have a practical role in patient safety across orthopedic, vascular and critical care environments, where managing pressure with more precision seems to contribute to better postoperative outcomes, and fewer complication rates.
Over the last five years the market has moved more and more toward digitally controlled, sensor-enabled pressure pump systems that plug into, and align with, wider hospital monitoring infrastructure. That shift really picked up after the COVID-19 pandemic since it highlighted the need for smoother patient management, increased intensive care capacity, and stronger focus on preventing hospital-acquired complications.
So as healthcare providers continue investing in modernizing surgical and acute care workflows, these advanced antithrombotic pressure pumps are starting to look like standard equipment not optional add-ons, which then creates ongoing replacement demand and supports longer-term market revenue via technology upgrades, plus broader clinical use.
Key Market Insights
- In North America , the United States pretty much dominates the Antithrombotic Pressure Pump Market, it grabs around 84% market share in 2025 ,and this is helped by advanced hospital infrastructure.
- Canada looks like the fastest mover in the 2025–2032 window, mainly because hospital modernization work keeps expanding, plus more surgical capacity investment is happening.
- Intermittent pneumatic pressure pumps are leading first, with close to 63% of the market in 2025, which shows how widely these are being used in orthopedic and vascular procedures.
- Portable antithrombotic pressure pumps come in next, holding the second-largest share. Hospitals seem to be prioritizing flexible patient mobility and shorter post-operative recovery pathways, so yeah they like portability.
- Smart connected pressure pump systems are expected to be the quickest grower through 2032 , backed by digital monitoring and electronic health record integration, that kind of setup.
- When it comes to applications , postoperative deep vein thrombosis prevention still stays dominant, it represents about 58% of total demand in 2025.
- Critical care and intensive care uses are emerging as the fastest-growing segment ,since preventive thrombosis management protocols are being expanded.
- For end-use revenue, hospitals account for nearly 72% of North America Antithrombotic Pressure Pump Market revenue in 2025, largely supported by high surgical procedure volumes.
- And for end users, ambulatory surgical centers are the fastest-growing category, since more outpatient procedures keep shifting away from inpatient facilities.
What are the Key Drivers, Restraints, and Opportunities in the North America Antithrombotic Pressure Pump Market?
The strongest growth catalyst for the North America Antithrombotic Pressure Pump Market is the broader uptake of evidence driven venous thromboembolism prevention protocols across hospitals and ambulatory surgical centers. Updated clinical guidelines, along with rising orthopedic , cardiovascular and bariatric surgical volumes have pushed providers to standardize mechanical thromboprophylaxis in a pretty steady way. Many facilities are moving away from conventional compression gear toward digitally controlled pressure pumps that deliver a more consistent pressure profile, enhance patient observation and also support quality-of-care goals. As this shift accelerates, manufacturers typically see higher equipment procurement, recurring accessory sales and longer term service income, which is kinda a big deal for cashflow.
The main structural drag still comes back to the steep capital cost of advanced pressure pump systems, plus the fragmented reimbursement landscape for mechanical thromboprophylaxis solutions. Smaller hospitals and outpatient facilities sometimes postpone replacement because their procurement budgets have to compete with imaging, robotics, and patient monitoring upgrades. Since reimbursement policies can differ widely across providers and purchasing decisions often follow long capital planning cycles, adoption ends up slower than the pace of technical development. That lag in turn, can hold back market revenue even when demand is clearly there.
A major opportunity ahead is the integration of connected pressure pumps with hospital digital ecosystems. Smart devices with wireless monitoring, automated pressure adjustments and electronic health record connectivity allow clinicians to follow therapy adherence and refine care pathways. On top of that, investments in digitally enabled hospitals.
What Has the Impact of Artificial Intelligence Been on the North America Antithrombotic Pressure Pump Market?
Artificial intelligence along with advanced digital technologies are gradually shifting the North American antithrombotic pressure pump industry, in a way that’s kind of steady but still noticeable. They do it by making device automation better, improving patient monitoring and also equipment management, a lot more smoothly. In recent years modern compression systems increasingly include smart control algorithms that can automatically tune inflation pressure and therapy cycles based on patient traits, which lowers the amount of manual setup needed. At the same time, clinical performance stays steady, even when different people are being treated. On top of that hospitals are adopting connected device platforms that kinda centralize equipment oversight, usage tracking, and maintenance timing across several departments, instead of juggling everything separately.
Machine learning models then look at past device performance , service histories, and utilization patterns. From that, they can support predictive maintenance , so biomedical engineering teams can flag components that should be replaced before they fail unexpectedly. These predictive features raise equipment availability, cut down on surprise downtime, help maintenance resources get used in a smarter manner , and in the end extend device lifetime too. When integration happens with hospital information systems the benefits widen as well, because treatment documentation becomes stronger, compliance reporting is easier to keep accurate, and asset management is more organized while workflow coordination feels a bit more efficient.
Still, AI adoption isn’t fully smooth, because integration costs can be high and many hospitals have fragmented information technology environments. A lot of facilities run mixed fleets of older medical equipment that don’t have standardized connectivity, and that constraint limits both the quality and the amount of data that advanced analytics needs. Until interoperability standards improve and larger clinical datasets start becoming available, the true impact of AI-enabled compression therapy systems will keep landing unevenly across healthcare providers.
Key Market Trends
- Since 2021 , hospitals have been speeding up the swap of legacy pneumatic pumps for digitally controlled setups that handle pressure tweaking automatically, plus real time monitoring , which is sort of a whole different operating style.
- Manufacturers now more often blend wireless connectivity with electronic health record platforms, so there’s less manual paperwork and the treatment trail stays clearer over time.
- Clinical buying choices have gradually moved away from just the initial equipment price , and they lean more on the total life cycle value, maintenance efficiency, and whether everything plays well with the hospital’s infrastructure.
- Ambulatory surgical centers have taken this up faster too, especially because outpatient orthopedic procedures grew a lot from 2022 through 2025.
- Meanwhile product development is going toward quieter, lighter, more portable compression systems , since these help people move easier during recovery, instead of feeling weighed down.
- Supply chains also look different since the pandemic, with manufacturers pushing more North American production and leaning on regional sourcing, just to reduce delivery risk, in general.
- Firms like Cardinal Health and Arjo have reinforced their positions by keeping up product innovation and also expanding their digital healthcare offerings, more and more.
- Sensor enabled compression technology has become one of the quickest moving areas, supporting personalized therapy and automated pressure optimization without as much guesswork.
- Healthcare providers are also now judging vendors based on cybersecurity readiness, ongoing software support, and long term digital integration, not only hardware performance.
North America Antithrombotic Pressure Pump Market Segmentation
By Product Type :
Intermittent pneumatic compression pumps support blood circulation via controlled inflation , and deflation cycles, and are used commonly during surgical recovery and prolonged bed rest. Sequential compression pumps create pressure in a planned sequence, so you can encourage a steady blood flow. Portable and battery-operated pumps improve mobility too, because they let therapy happen outside fixed hospital settings, which is a bit more practical.
Single-chamber pumps deliver pressure through one compartment and tend to fit routine treatment needs, while multi-chamber pumps provide more controlled compression across different sections of the limb. Smart pumps include digital controls and monitoring functions, and that helps improve treatment accuracy. The other type category includes specialized products that are developed for specific clinical situations and changing healthcare requirements.

By Application :
Deep vein thrombosis prevention stays as a primary application, since compression therapy supports healthy blood circulation during long periods of limited movement. Post-surgical care also matters a lot, as controlled compression helps reduce the possibility of clot formation after major procedures. Critical care environments rely on these systems for patients with limited mobility , where movement is difficult.
Orthopedic procedures often call for compression therapy after joint replacement and fracture treatment, to support recovery more reliably. Vascular disorders, trauma care, and rehabilitation programs also benefit from controlled pressure systems that promote circulation during healing. The remaining uses include specialized medical treatments where compression therapy supports patient management in a more targeted way.
By End User :
Hospitals account for the largest share, mostly because big surgical volumes and intensive patient care mean compression therapy equipment gets used, all the time and in a pretty steady stream. Ambulatory surgical centers keep expanding adoption too as outpatient procedures become more everyday, and less unusual. Clinics also rely on these systems for routine treatment and later follow up, across multiple patient groups, with slightly different needs depending on the situation.
Rehabilitation centers help recovery through structured compression therapy programs, while homecare settings push for treatment continuity after patients leave the hospital. Long term care centers use these devices for patients with extended mobility limitations, basically to support comfort over longer periods. Specialty centers and other healthcare facilities choose equipment that fits, individual treatment requirements and care plans rather than a one size approach.
By Technology :
Digital monitoring lets healthcare professionals observe therapy settings with more precision and keep treatment consistent from session to session. Wireless connectivity supports secure data sharing between devices and hospital information systems which then improves workflow efficiency. AI enabled systems assist with therapy adjustments by analyzing patient information and the operating conditions they face.
Pressure sensors make compression more accurate, since they measure the applied force during treatment sessions, not just at the start. Portable systems add flexibility across different care environments, while smart monitoring and remote monitoring help healthcare providers oversee therapy without being at the bedside constantly. The remaining technologies include newer innovations introduced to boost device performance and clinical efficiency.
By Distribution Channel :
Direct sales let manufacturers build longer relationships with healthcare providers, while also giving hands on product training and technical support, sort of ongoing coaching. At the same time, medical distributors widen product availability across different regions by using their established supply networks and regular pathways. Hospital procurement departments usually buy equipment based on clinical needs, quality standards, and those long term service agreements that keep things stable, even when everything changes.
Meanwhile online sales keep catching more attention in a few product groups, mainly because purchasing feels easier and comparisons look clearer. Specialty suppliers tend to concentrate on advanced medical equipment for particular healthcare requirements, whereas group purchasing organizations and dealers raise overall supply efficiency through negotiated contracts, kind of streamlining the process. And the rest of the distribution channels help maintain access across a variety of healthcare settings, so providers are not stuck in only one option.
What are the Key Use Cases Driving the North America Antithrombotic Pressure Pump Market?
The largest share of demand really comes from postoperative care in hospitals , where these antithrombotic pressure pumps help lower the risk of deep vein thrombosis after orthopedic, cardiovascular, and general surgical work . Because the surgical volumes stay high, and thrombosis prevention protocols are pretty standardized, this ends up as the main scenario, which in turn supports steady equipment usage and replacement buys .
Adoption is also spreading across ambulatory surgical centers and rehabilitation facilities , mostly because more procedures are moving toward outpatient paths . In these places the pressure pump systems get used to back patient recovery, help encourage healthier blood circulation during limited mobility, and keep complications down without needing longer hospital stays . And the growing use in trauma care is making the momentum stronger too .
Newer opportunities are starting to appear in homecare and long term care environments, where portable plus digitally connected systems allow extended therapy after discharge . Remote monitoring tools and smart pressure adjustment features are expected to make adoption easier , as healthcare providers lean more into decentralized patient management and improve continuity of care beyond the usual clinical walls.
|
Report Metrics |
Details |
|
Market size value in 2025 |
USD 73.8 Million |
|
Market size value in 2026 |
USD 78.4 Million |
|
Revenue forecast in 2033 |
USD 121.7 Million |
|
Growth rate |
CAGR of 6.48% from 2026 to 2033 |
|
Base year |
2025 |
|
Historical data |
2021 - 2024 |
|
Forecast period |
2026 - 2033 |
|
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
|
Regional scope |
North America (Canada, The United States, and Mexico) |
|
Key company profiled |
Cardinal Health, Medtronic, Arjo, Zimmer Biomet, DJO Global, Bio Compression Systems, Devon Medical, Huntleigh Healthcare, Tactile Medical, B. Braun, Stryker, Getinge, Convatec, Essity, Mego Afek. |
|
Customization scope |
Free report customization (country, regional & segment scope). Avail customized purchase options to meet your exact research needs. |
|
Report Segmentation |
By Product Type (Intermittent Pneumatic Compression Pumps, Sequential Compression Pumps, Portable Pumps, Battery-Operated Pumps, Single-Chamber Pumps, Multi-Chamber Pumps, Smart Pumps, Others); By Application (Deep Vein Thrombosis Prevention, Post-Surgical Care, Critical Care, Orthopedic Procedures, Vascular Disorders, Trauma Care, Rehabilitation, Others); By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Rehabilitation Centers, Homecare, Long-Term Care Centers, Specialty Centers, Others); By Technology (Digital Monitoring, Wireless Connectivity, AI-Enabled Systems, Pressure Sensors, Portable Systems, Smart Monitoring, Remote Monitoring, Others); By Distribution Channel (Direct Sales, Medical Distributors, Hospital Procurement, Online Sales, Specialty Suppliers, GPOs, Dealers, Others). |
Which Regions are Driving the North America Antithrombotic Pressure Pump Market Growth?
The United States kinda holds the largest portion of the North America Antithrombotic Pressure Pump Market, mainly because it has really advanced healthcare infrastructure , a high volume of surgical cases , and very clear clinical guidelines for preventing venous thromboembolism. Also, strong reimbursement frameworks make it easier for hospitals to keep investing in modern compression therapy devices, which tends to improve patient outcomes and lower postoperative complications. Healthcare providers keep spending capital in a steady way too, so older medical devices get swapped out more routinely for digitally enabled systems. And you can see ongoing cooperation between medical device manufacturers, healthcare networks, and research institutions, that part helps product development and keeps long-term market growth moving.
Canada, on the other hand , brings in a smaller share but still fairly stable regional revenue, due to steady healthcare investment and more structured procurement. Compared with the United States, progress here leans a bit more on publicly financed healthcare programs, which focus on long-range clinical benefit and standardized patient care. Hospitals still move forward with advanced compression therapy solutions, often as part of wider modernization programs and patient safety initiatives. That kind of steady investment climate means demand stays more predictable, for vendors that supply trustworthy, clinically validated equipment.
Mexico is expected to see the fastest growth through 2033, as healthcare infrastructure expands, and as access to advanced surgical care gets better across both public and private hospitals. Lately, investments for hospital development and medical technology have kind of pushed more adoption of modern patient management equipment, including antithrombotic pressure pumps. There is also greater involvement from private healthcare providers, and that is speeding up equipment upgrades while new facilities bring in more advanced digital systems too. This whole momentum creates attractive opportunities for manufacturers and investors, who are looking for early market expansion and stronger regional distribution networks throughout the forecast period.
Who are the Key Players in the North America Antithrombotic Pressure Pump Market and How Do They Compete?
The competitive environment is still moderately consolidated, with companies that already exist in medical devices competing mostly by how they develop technology, how well the clinical results hold up, and how good their service feels, not just by price , alone . Hospitals are also looking more and more at suppliers through digital integration, device reliability, training support, and whether they can keep maintaining things over the long run. So, this change tends to push manufacturers to improve product portfolios by adding smart monitoring features, and also expand their technical assistance and clinical education services , just to keep the customer relationship steady.
Cardinal Health leans into broad hospital distribution and integrated clinical solutions , so healthcare providers can source compression therapy products through well known procurement networks. Arjo sets itself apart by pairing patient mobility solutions with compression therapy products , so it can fit into broader hospital care pathways. Ongoing investment in connected healthcare technologies helps keep retention strong and opens up more long term service chances.
Zimmer Biomet builds its advantage by tying compression therapy products to orthopedic surgical care, which makes demand show up naturally within joint replacement programs. Medline Industries grows market presence via large supply chain capabilities and value-added clinical support that makes purchasing simpler for healthcare facilities. Bio Compression Systems focuses on advanced compression technologies for vascular and lymphatic therapy, and that way it competes through concentrated product know-how and ongoing refinement of the products themselves.
Company List
- Cardinal Health
- Medtronic
- Arjo
- Zimmer Biomet
- DJO Global
- Bio Compression Systems
- Devon Medical
- Huntleigh Healthcare
- Tactile Medical
- B. Braun
- Stryker
- Getinge
- Convatec
- Essity
- Mego Afek
Recent Development News
In 2025, Zimmer Biomet continued expanding its VasoPress® Digital Mini with Timer compression therapy portfolio for deep vein thrombosis prevention. The company emphasized digital therapy tracking and compliance monitoring capabilities to improve postoperative patient management and clinical documentation.
Source: https://www.zimmerbiomet.com/
In 2025, Arjo expanded the clinical promotion of its Flowtron Active Compression System through updated clinical evidence and product support resources. The initiative reinforced the company's focus on evidence-based venous thromboembolism prevention and supported broader adoption of intermittent pneumatic compression therapy across healthcare facilities.
Source: https://www.arjo.com/
What Strategic Insights Define the Future of the North America Antithrombotic Pressure Pump Market?
The North America Antithrombotic Pressure Pump Market is expected to veer toward connected, data- driven compression therapy setups, that basically merge smart pressure management with hospital wide digital care platforms. It's going to be shaped by how much the industry keeps leaning into value based healthcare, where providers put more money into tools that help patient outcomes, lower avoidable complications, and also back up clinical documentation.
There’s also a less obvious concern, a sort of hidden risk, with procurement becoming more centralized across big healthcare networks, and group purchasing organizations. That can crank up pricing pressure, and it can make it harder for smaller manufacturers to even enter the market, or keep momentum once they’re in.
At the same time, there’s an emerging opening in remote compression therapy for home recovery, supported by wireless monitoring along with cloud connected patient management platforms. This is happening because care is expanding beyond hospitals, and more recovery is handled in post-acute environments. Companies that move early on interoperable digital solutions, cybersecurity measures, and solid evidence based clinical validation should end up in a better spot to win long-term contracts, stand apart from competitors, and capture more future growth across both acute care and after discharge settings.
North America Antithrombotic Pressure Pump Market Report Segmentation
By Product Type
- Intermittent Pneumatic Compression Pumps
- Sequential Compression Pumps
- Portable Pumps
- Battery-Operated Pumps
- Single-Chamber Pumps
- Multi-Chamber Pumps
- Smart Pumps
By Application
- Deep Vein Thrombosis Prevention
- Post-Surgical Care
- Critical Care
- Orthopedic Procedures
- Vascular Disorders
- Trauma Care
- Rehabilitation
By End User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Rehabilitation Centers
- Homecare
- Long-Term Care Centers
- Specialty Centers
By Technology
- Digital Monitoring
- Wireless Connectivity
- AI-Enabled Systems
- Pressure Sensors
- Portable Systems
- Smart Monitoring
- Remote Monitoring
By Distribution Channel
- Direct Sales
- Medical Distributors
- Hospital Procurement
- Online Sales
- Specialty Suppliers
- GPOs
- Dealers
Frequently Asked Questions
Find quick answers to common questions.
The North America Antithrombotic Pressure Pump Market size is USD 121.7 Million in 2033.
Key segments for the North America Antithrombotic Pressure Pump Market are By Product Type (Intermittent Pneumatic Compression Pumps, Sequential Compression Pumps, Portable Pumps, Battery-Operated Pumps, Single-Chamber Pumps, Multi-Chamber Pumps, Smart Pumps, Others); By Application (Deep Vein Thrombosis Prevention, Post-Surgical Care, Critical Care, Orthopedic Procedures, Vascular Disorders, Trauma Care, Rehabilitation, Others); By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Rehabilitation Centers, Homecare, Long-Term Care Centers, Specialty Centers, Others); By Technology (Digital Monitoring, Wireless Connectivity, AI-Enabled Systems, Pressure Sensors, Portable Systems, Smart Monitoring, Remote Monitoring, Others); By Distribution Channel (Direct Sales, Medical Distributors, Hospital Procurement, Online Sales, Specialty Suppliers, GPOs, Dealers, Others).
Major North America Antithrombotic Pressure Pump Market players are Cardinal Health, Medtronic, Arjo, Zimmer Biomet, DJO Global, Bio Compression Systems, Devon Medical, Huntleigh Healthcare, Tactile Medical, B. Braun, Stryker, Getinge, Convatec, Essity, Mego Afek.
The North America Antithrombotic Pressure Pump Market size is USD 73.8 Million in 2025.
The North America Antithrombotic Pressure Pump Market CAGR is 6.48% from 2026 to 2033.
- Cardinal Health
- Medtronic
- Arjo
- Zimmer Biomet
- DJO Global
- Bio Compression Systems
- Devon Medical
- Huntleigh Healthcare
- Tactile Medical
- B. Braun
- Stryker
- Getinge
- Convatec
- Essity
- Mego Afek
Recently Published Reports
-
Apr 2026
AI in Diabetic Retinopathy Market
AI in Diabetic Retinopathy Market Size, Share & Analysis Report By Type (Screening AI Systems, Diagnostic AI Systems, and Predictive AI Models), By Application Segment (Hospitals, Ophthalmology Clinics, Diagnostic Centers, and Research and Development), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 - 2031
-
Apr 2026
Psychometric Tests Market
Psychometric Tests Market Size, Share & Analysis Report By Type (Personality Tests, Ability/Aptitude Tests, Skill/Knowledge Tests, and Others), By Application (Talent Acquisition and Talent Management), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
-
Apr 2026
Rare Biological Sample Collection Market
Rare Biological Sample Collection Market Size, Share & Analysis Report By Type (Isolation Kits & Reagent, Blood Collection Tubes, and Others), By Application (Oncology, Transcriptomics, Pharmacogenomics, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
-
Jul 2026
Diabetic Retinopathy Market
Diabetic Retinopathy Market Size, Share & Analysis Report By Type (Proliferative Diabetic Retinopathy, and Diabetic Macular Edema (DME)), By Treatment Type (Anti VEGF Drug, Steroid Implants, Laser Surgeries, and Vitrectomy), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
Our Clients
.jpg)






